Huron Consulting HURN

NASDAQ HURN

$149.88 +0.21 (+0.14%)

As of: Sep 10, 2026 · 1:13 PM EDT

Key Stats

Market Cap2.43 Bn

P/E21.02

P/S1.73

Div. Yield0.00

Total Debt (Qtr)832.81 Mn

Revenue Growth (1y) (Qtr)15.36

Add ratio to table…

About

Huron Consulting Group Inc. is a global professional services firm that partners with clients to create sound strategies, optimize operations, accelerate digital transformation, and empower businesses to own their future. The firm operates through a combination of deep industry expertise and broad service offerings to deliver sustainable results for organizations across multiple sectors. Headquartered in Chicago, Illinois, Huron maintains additional locations in the United…

Huron generates revenue primarily through its consulting and managed services, as well as its digital capabilities, which include technology and analytics services, technology-related managed services, and software products. The firm serves clients across healthcare, education, financial services, industrials and manufacturing, energy and utilities, public sector, and other commercial industries. Revenue is derived from strategic, operational, financial, people, and organizational consulting engagements, managed services outsourcing, and proprietary software offerings that support long-term client relationships and drive lasting impact.

The company operates through the following segments: Healthcare, Education, and Commercial.

Healthcare: This segment serves acute care providers such as national and regional health systems, academic health systems, community health systems, federal health systems, and public, children’s, and critical access hospitals, as well as non-acute care providers including physician practices, medical groups, payors, and long-term or post-acute providers. Offerings include financial and operational performance improvement consulting spanning revenue cycle, business operations, and care delivery transformation; organizational transformation; revenue cycle managed services and outsourcing; financial and capital advisory consulting; and strategy and innovation consulting. Digital services encompass technology and analytic-related services including core systems of record such as electronic health record (EHR), enterprise resource planning (ERP), enterprise performance management (EPM), and customer relationship management (CRM) systems; data management, AI and automation; technology managed services; and payor core administration systems. Proprietary software products are also delivered to the healthcare industry, including recent enhancements from the acquisition of Eclipse Insights LLC in June 2025 and the consulting services division of AXIOM Systems Consulting Services, Inc. in November 2025.
Education: This segment serves public and private colleges and universities, research institutes, not-for-profit organizations, and other education-related organizations. Consulting and managed services include research-focused consulting and managed services; strategy and operations consulting spanning finance, accounting, operations, athletics, organization and talent strategy, and student and academic strategy; and advancement and fundraising consulting services strengthened by the acquisition of Grenzebach Glier and Associates (GG+A) in March 2024 and Advancement Resources and Halpin Partnership Limited in March 2025. Digital offerings span technology and analytic-related services such as student information, ERP, EPM, and CRM systems; data management, AI and automation; and technology managed services. Product offerings include the Huron Research Suite, a leading software suite designed to facilitate and improve research administration service delivery and compliance.
Commercial: This segment serves industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Primary buyers include chief executive officers, chief financial officers, chief strategy officers, chief human resources officers, chief operating officers, chief risk officers, and organizational advisors such as lenders and law firms. The firm has a deep focus on financial services, industrials and manufacturing, energy and utilities, and the public sector, while opportunistically serving professional and business services, life sciences, consumer products, and retail. Services include digital services and software products, financial and capital advisory (special situation and corporate finance advisory), regulatory compliance and risk management consulting and managed services, strategy and innovation consulting, and financial and operational performance improvement consulting. Recent acquisitions include TVG-Treliant Holdings, LLC (Treliant) in the third quarter of 2025 and Wilson Perumal and Company, Inc. (WP&C), a strategy and operations consulting firm specializing in operational efficiency and improved growth and profitability.

Huron Consulting Group Inc. holds leading market positions in healthcare and education, providing comprehensive offerings to the largest health systems, academic medical centers, colleges and universities, and research institutes in the United States and abroad. The company competes in a highly fragmented professional services industry that includes strategy, business operations, technology, and financial advisory consulting firms; general management consulting firms; consulting practices of major accounting firms; technical and economic advisory firms; regional and specialty consulting firms; consulting divisions of technology partners; and internal professional resources of organizations. Competitive advantages stem from reputation, industry and capability expertise, ability to attract and retain top talent, capacity to deliver high-quality, measurable results, and a balanced portfolio of offerings that enable favorable positioning despite varying geographic footprints and resource levels among competitors.

Huron serves over 2,000 clients across industries, including hospitals, health systems, and academic medical centers; colleges, universities, and research institutes; banks, asset managers, insurance companies, and private equity firms; oil and gas and utilities companies; manufacturing organizations; not-for-profit organizations; and the public sector. The company’s 10 largest clients accounted for approximately 19% of consolidated revenues in 2025. No specific client names are disclosed in the filing.

Investment Thesis

▲ Bull case

Huron Consulting Group Inc. is positioned to capitalize on the accelerating demand for AI-enabled healthcare solutions, a trend that management did not fully quantify in the earnings call but is reinforced by the recent acquisition of RelateCare. The healthcare segment, which generated 51% of total RBR in Q1 2026, is experiencing structural transformation as providers grapple with constrained reimbursements, rising operational costs, and labor shortages—challenges that necessitate AI-driven workflow optimization across clinical, administrative, and financial functions. While management highlighted strong demand for performance improvement and revenue cycle managed services, they understated the pace at which AI integration is becoming a prerequisite for competitive differentiation in healthcare. The RelateCare acquisition adds AI-enabled clinical and patient access solutions that directly address pain points in scheduling, triage, and clinician engagement—areas where health systems are increasingly willing to pay premiums for measurable operational and financial outcomes. This capability extends Huron’s existing managed services footprint, which already grew 42% year-over-year in Q1 2026, creating a flywheel effect where AI-enhanced services improve utilization, reduce delivery costs, and increase contract stickiness. Given that the AI services market is forecasted to grow in the double digits annually and Huron’s 40% digital revenue base provides a strong talent foundation, the company is well-positioned to monetize this shift organically without relying on costly acquisitions, thereby protecting margins while expanding total addressable market.
The commercial segment’s organic growth of 8% in Q1 2026—driven by a 50% surge in consulting revenue—reveals a hidden catalyst that management framed as cyclical but may represent a structural shift in client demand for integrated strategy and operations advisory. While commercial industries face persistent cost inflation, supply chain realignment, and geopolitical uncertainty, Huron’s ability to deliver end-to-end solutions combining financial advisory, strategy, and digital transformation is becoming a non-negotiable requirement for clients navigating AI-enabled operating model shifts. The 22.3% RBR growth in commercial, excluding acquisition impacts, significantly outpaces the education segment’s 3.8% growth and even the healthcare segment’s 10% organic growth, suggesting the commercial business is benefiting from secular demand for resilience-focused consulting that transcends temporary macroeconomic headwinds. Management noted timing-related drag in digital capabilities but failed to emphasize that the consulting surge reflects clients prioritizing strategic redesign over standalone technology implementations—a trend that favors Huron’s integrated service model over pure-play digital vendors. This shift is further supported by the company’s strong backlog and near-record pipeline across all segments, which provides visibility into sustained demand beyond quarterly fluctuations. As clients accelerate AI adoption to improve agility and decision-making, Huron’s embedded expertise in driving financial outcomes through technology-enabled process redesign positions it to capture higher-margin, long-term engagements that are less susceptible to budget cuts during economic soft patches.
Huron’s capital allocation strategy, particularly its aggressive share repurchase program, is an underappreciated driver of future EPS growth that the market may be overlooking due to near-term leverage concerns. In Q1 2026, the company repurchased 1.1 million shares (6.5% of beginning-of-year outstanding) for $155.5 million, accelerating a program that has already returned 5 million shares (25% of post-2022 outstanding) since December 2022. While management acknowledged the leverage ratio rose to 3.1x adjusted EBITDA due to bonus payouts and buybacks, they reaffirmed commitment to reducing leverage to the low twos by year-end 2026 through disciplined pacing of repurchases and continued free cash flow generation. The market may be underestimating the compounding effect of share count reduction on EPS: even if adjusted net income remains flat at $30 million annually, the reduced share base from buybacks would lift adjusted EPS by over 20% by year-end 2026 assuming similar repurchase pacing. Combined with projected low double-digit RBR growth and margin expansion to 14.5–15% adjusted EBITDA margin, this creates a powerful tailwind for EPS growth that could exceed the guided $8.35–$9.15 range. Furthermore, the company’s strong free cash flow conversion—historically delivering $180–$220 million annually—provides ample capacity to sustain buybacks while funding tuck-in M&A, creating a dual lever for shareholder value creation that is not fully reflected in current valuation multiples.

Huron Consulting Group Inc. is positioned to capitalize on the accelerating demand for AI-enabled healthcare solutions, a trend that management did not fully quantify in the earnings call but is reinforced by the recent acquisition of RelateCare. The healthcare segment, which generated 51% of total RBR in Q1 2026, is experiencing structural transformation as providers grapple with constrained reimbursements, rising operational costs, and labor shortages—challenges that necessitate AI-driven workflow optimization across clinical, administrative, and financial functions. While management highlighted strong demand for performance improvement and revenue cycle managed services, they understated the pace at which AI integration is becoming a prerequisite for competitive differentiation in healthcare. The RelateCare acquisition adds AI-enabled clinical and patient access solutions that directly address pain points in scheduling, triage, and clinician engagement—areas where health systems are increasingly willing to pay premiums for measurable operational and financial outcomes. This capability extends Huron’s existing managed services footprint, which already grew 42% year-over-year in Q1 2026, creating a flywheel effect where AI-enhanced services improve utilization, reduce delivery costs, and increase contract stickiness. Given that the AI services market is forecasted to grow in the double digits annually and Huron’s 40% digital revenue base provides a strong talent foundation, the company is well-positioned to monetize this shift organically without relying on costly acquisitions, thereby protecting margins while expanding total addressable market.
The commercial segment’s organic growth of 8% in Q1 2026—driven by a 50% surge in consulting revenue—reveals a hidden catalyst that management framed as cyclical but may represent a structural shift in client demand for integrated strategy and operations advisory. While commercial industries face persistent cost inflation, supply chain realignment, and geopolitical uncertainty, Huron’s ability to deliver end-to-end solutions combining financial advisory, strategy, and digital transformation is becoming a non-negotiable requirement for clients navigating AI-enabled operating model shifts. The 22.3% RBR growth in commercial, excluding acquisition impacts, significantly outpaces the education segment’s 3.8% growth and even the healthcare segment’s 10% organic growth, suggesting the commercial business is benefiting from secular demand for resilience-focused consulting that transcends temporary macroeconomic headwinds. Management noted timing-related drag in digital capabilities but failed to emphasize that the consulting surge reflects clients prioritizing strategic redesign over standalone technology implementations—a trend that favors Huron’s integrated service model over pure-play digital vendors. This shift is further supported by the company’s strong backlog and near-record pipeline across all segments, which provides visibility into sustained demand beyond quarterly fluctuations. As clients accelerate AI adoption to improve agility and decision-making, Huron’s embedded expertise in driving financial outcomes through technology-enabled process redesign positions it to capture higher-margin, long-term engagements that are less susceptible to budget cuts during economic soft patches.
Huron’s capital allocation strategy, particularly its aggressive share repurchase program, is an underappreciated driver of future EPS growth that the market may be overlooking due to near-term leverage concerns. In Q1 2026, the company repurchased 1.1 million shares (6.5% of beginning-of-year outstanding) for $155.5 million, accelerating a program that has already returned 5 million shares (25% of post-2022 outstanding) since December 2022. While management acknowledged the leverage ratio rose to 3.1x adjusted EBITDA due to bonus payouts and buybacks, they reaffirmed commitment to reducing leverage to the low twos by year-end 2026 through disciplined pacing of repurchases and continued free cash flow generation. The market may be underestimating the compounding effect of share count reduction on EPS: even if adjusted net income remains flat at $30 million annually, the reduced share base from buybacks would lift adjusted EPS by over 20% by year-end 2026 assuming similar repurchase pacing. Combined with projected low double-digit RBR growth and margin expansion to 14.5–15% adjusted EBITDA margin, this creates a powerful tailwind for EPS growth that could exceed the guided $8.35–$9.15 range. Furthermore, the company’s strong free cash flow conversion—historically delivering $180–$220 million annually—provides ample capacity to sustain buybacks while funding tuck-in M&A, creating a dual lever for shareholder value creation that is not fully reflected in current valuation multiples.

▼ Bear case

Huron Consulting Group Inc. faces significant margin pressure in its healthcare segment that management failed to adequately address, despite reporting flat operating income margins at 28.4% year-over-year in Q1 2026. While the segment delivered record RBR of $225.2 million and 13.5% growth, the flat margin trend contrasts with the company’s broader narrative of margin expansion and raises concerns about pricing power in a increasingly competitive landscape. Healthcare providers are under intense financial strain from constrained reimbursements and rising labor costs, which may be forcing them to demand more stringent fee structures or shift toward lower-margin, transaction-based engagements—particularly as Huron expands its managed services footprint through acquisitions like RelateCare. The 42% year-over-year growth in managed services revenue, while impressive, risks diluting overall segment profitability if these services are delivered at lower margins than traditional consulting, especially given the labor-intensive nature of revenue cycle and patient access outsourcing. Management highlighted AI integration as a growth driver but did not disclose whether AI-enabled services are commanding premium pricing or merely defending existing price points in a commoditizing market. Furthermore, the increase in DSO to 82 days from 79 days year-over-year—attributed to larger projects with performance-based fee elements—suggests potential revenue recognition delays and collection risks that could undermine cash flow conversion if milestones are not met, creating a hidden working capital drag that is not fully captured in adjusted EBITDA metrics.
The education segment’s modest 3.8% RBR growth in Q1 2026, coupled with declining utilization in digital capabilities and a 6.1% year-over-year decrease in revenue-generating professionals, signals deeper structural challenges that management characterized as temporary but may reflect irreversible shifts in higher education financing and demand. While management cited strong demand for digital offerings and noted a stronger buying environment year-over-year, they overlooked persistent headwinds: declining international enrollment, eroding public confidence in traditional degrees, funding declines, and heightened regulatory scrutiny that are forcing institutions to prioritize cost containment over strategic transformation. The segment’s operating income margin improved to 21.6% from 18.8%, but this was driven primarily by reduced compensation costs—a sign of underinvestment in talent or delayed hiring rather than organic pricing power or scale benefits. With higher education institutions increasingly adopting austerity measures and delaying non-essential consulting engagements, Huron’s reliance on long-term transformation projects may be misaligned with clients’ immediate need for short-term financial relief. The lack of centralization in decision-making, which management acknowledged as a sales motion challenge, further complicates deal execution and increases sales cycle variability, making revenue less predictable than in healthcare or commercial segments. As institutions continue to navigate financial sustainability crises, demand for Huron’s services may remain tethered to episodic funding cycles rather than secular growth, creating a persistent drag on segment performance that could limit the company’s ability to achieve low double-digit RBR growth targets without outsized contributions from healthcare and commercial.
Huron’s rising leverage ratio of 3.1x adjusted EBITDA as of March 31, 2026—up from 2.2x a year earlier—represents a material financial risk that the market may be underpricing, despite management’s commitment to reducing it to the low twos by year-end. The increase was driven almost entirely by Q1 2026 actions: $155.5 million in share repurchases and annual bonus payouts, which temporarily inflated net debt to $829.5 million. While management framed this as seasonal and reversible, the pace of repurchases—accelerated due to declining stock price—suggests potential overreliance on financial engineering to support share price rather than fundamental business performance. More concerning is the company’s growing dependence on debt-funded capital allocation: total long-term debt increased to $834.7 million from $489.7 million year-over-year, reflecting a strategy that uses balance sheet leverage to fund both buybacks and acquisitions. If free cash flow generation falls short of the $180–$220 million annual target due to project delays, higher tax rates, or integration costs from acquisitions like RelateCare, the company may be forced to slow repurchases or delay M&A, undermining two key pillars of its shareholder return strategy. Furthermore, the leverage ratio is calculated using adjusted EBITDA, which excludes non-cash charges like the $3.8 million contingent consideration remeasurement in Q1 2026—a figure that could recur if acquisition earnouts are tied to volatile performance metrics, creating additional earnings volatility that management’s non-GAAP metrics obscure. In a rising interest rate environment, this debt load could constrain financial flexibility and increase vulnerability to macroeconomic shocks, particularly if client spending on discretionary consulting services softens during an economic downturn.

Huron Consulting Group Inc. faces significant margin pressure in its healthcare segment that management failed to adequately address, despite reporting flat operating income margins at 28.4% year-over-year in Q1 2026. While the segment delivered record RBR of $225.2 million and 13.5% growth, the flat margin trend contrasts with the company’s broader narrative of margin expansion and raises concerns about pricing power in a increasingly competitive landscape. Healthcare providers are under intense financial strain from constrained reimbursements and rising labor costs, which may be forcing them to demand more stringent fee structures or shift toward lower-margin, transaction-based engagements—particularly as Huron expands its managed services footprint through acquisitions like RelateCare. The 42% year-over-year growth in managed services revenue, while impressive, risks diluting overall segment profitability if these services are delivered at lower margins than traditional consulting, especially given the labor-intensive nature of revenue cycle and patient access outsourcing. Management highlighted AI integration as a growth driver but did not disclose whether AI-enabled services are commanding premium pricing or merely defending existing price points in a commoditizing market. Furthermore, the increase in DSO to 82 days from 79 days year-over-year—attributed to larger projects with performance-based fee elements—suggests potential revenue recognition delays and collection risks that could undermine cash flow conversion if milestones are not met, creating a hidden working capital drag that is not fully captured in adjusted EBITDA metrics.
The education segment’s modest 3.8% RBR growth in Q1 2026, coupled with declining utilization in digital capabilities and a 6.1% year-over-year decrease in revenue-generating professionals, signals deeper structural challenges that management characterized as temporary but may reflect irreversible shifts in higher education financing and demand. While management cited strong demand for digital offerings and noted a stronger buying environment year-over-year, they overlooked persistent headwinds: declining international enrollment, eroding public confidence in traditional degrees, funding declines, and heightened regulatory scrutiny that are forcing institutions to prioritize cost containment over strategic transformation. The segment’s operating income margin improved to 21.6% from 18.8%, but this was driven primarily by reduced compensation costs—a sign of underinvestment in talent or delayed hiring rather than organic pricing power or scale benefits. With higher education institutions increasingly adopting austerity measures and delaying non-essential consulting engagements, Huron’s reliance on long-term transformation projects may be misaligned with clients’ immediate need for short-term financial relief. The lack of centralization in decision-making, which management acknowledged as a sales motion challenge, further complicates deal execution and increases sales cycle variability, making revenue less predictable than in healthcare or commercial segments. As institutions continue to navigate financial sustainability crises, demand for Huron’s services may remain tethered to episodic funding cycles rather than secular growth, creating a persistent drag on segment performance that could limit the company’s ability to achieve low double-digit RBR growth targets without outsized contributions from healthcare and commercial.
Huron’s rising leverage ratio of 3.1x adjusted EBITDA as of March 31, 2026—up from 2.2x a year earlier—represents a material financial risk that the market may be underpricing, despite management’s commitment to reducing it to the low twos by year-end. The increase was driven almost entirely by Q1 2026 actions: $155.5 million in share repurchases and annual bonus payouts, which temporarily inflated net debt to $829.5 million. While management framed this as seasonal and reversible, the pace of repurchases—accelerated due to declining stock price—suggests potential overreliance on financial engineering to support share price rather than fundamental business performance. More concerning is the company’s growing dependence on debt-funded capital allocation: total long-term debt increased to $834.7 million from $489.7 million year-over-year, reflecting a strategy that uses balance sheet leverage to fund both buybacks and acquisitions. If free cash flow generation falls short of the $180–$220 million annual target due to project delays, higher tax rates, or integration costs from acquisitions like RelateCare, the company may be forced to slow repurchases or delay M&A, undermining two key pillars of its shareholder return strategy. Furthermore, the leverage ratio is calculated using adjusted EBITDA, which excludes non-cash charges like the $3.8 million contingent consideration remeasurement in Q1 2026—a figure that could recur if acquisition earnouts are tied to volatile performance metrics, creating additional earnings volatility that management’s non-GAAP metrics obscure. In a rising interest rate environment, this debt load could constrain financial flexibility and increase vulnerability to macroeconomic shocks, particularly if client spending on discretionary consulting services softens during an economic downturn.

Consolidation Items Breakdown of Revenue (2025)

Peer group

Peer Comparison

Companies in the Consulting

S.No.	Ticker	Company	match	Market Cap	P/E	P/S	Total Debt (Qtr)
1	ACN	Accenture plc	primary	108.90 Bn	13.72	1.49	5.14 Bn
2	ULS	UL Solutions Inc.	primary	14.47 Bn	27.41	4.60	0.30 Bn
3	IT	Gartner Inc	primary	11.38 Bn	14.67	1.76	2.98 Bn
4	TTEK	Tetra Tech Inc	primary	9.18 Bn	21.06	1.81	0.85 Bn
5	BAH	Booz Allen Hamilton Holding Corp	primary	9.06 Bn	11.65	0.82	3.96 Bn
6	G	Genpact LTD	primary	5.84 Bn	10.02	1.11	1.21 Bn
7	FCN	Fti Consulting, Inc	primary	4.33 Bn	17.12	1.10	1.02 Bn
8	KFY	Korn Ferry	primary	4.04 Bn	14.39	1.38	0.40 Bn

Huron Consulting HURN

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Consolidation Items Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password